Sabin Vaccine Institute Receives Additional $34.5 Million from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
21 oct. 2021 09h47 HE
|
The Sabin Vaccine Institute
Washington DC, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the...
Sabin Vaccine Institute Appoints Filip Dubovsky to Board of Trustees
17 oct. 2019 10h00 HE
|
The Sabin Vaccine Institute
Washington, D.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that Dr. Filip Dubovsky, head of clinical engagement and policy at AstraZeneca, has joined its...